235 related articles for article (PubMed ID: 35077741)
1. Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy.
Huang X; Wu W; Jing D; Yang L; Guo H; Wang L; Zhang W; Pu F; Shao Z
J Control Release; 2022 Mar; 343():107-117. PubMed ID: 35077741
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of lncRNA MEG3 inhibits viability, migration, and invasion and promotes apoptosis by sponging miR-127 in osteosarcoma cell.
Wang Y; Kong D
J Cell Biochem; 2018 Jan; 119(1):669-679. PubMed ID: 28636101
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression.
Sun L; Yang C; Xu J; Feng Y; Wang L; Cui T
DNA Cell Biol; 2016 Dec; 35(12):812-818. PubMed ID: 27860482
[TBL] [Abstract][Full Text] [Related]
4. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
Zhang SZ; Cai L; Li B
Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of miR-664a interferes with the migration of osteosarcoma cells via modulation of MEG3.
Sahin Y; Altan Z; Arman K; Bozgeyik E; Koruk Ozer M; Arslan A
Biochem Biophys Res Commun; 2017 Aug; 490(3):1100-1105. PubMed ID: 28669734
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
Tian ZZ; Guo XJ; Zhao YM; Fang Y
Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
[TBL] [Abstract][Full Text] [Related]
8. MEG3 targets miR-184 and Wnt/β-catenin and modulates properties of osteosarcoma.
Li L; Pei S; Sun N
Front Biosci (Landmark Ed); 2020 Jun; 25(10):1901-1912. PubMed ID: 32472764
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG3 promotes chemosensitivity of osteosarcoma by regulating antitumor immunity via miR-21-5p/p53 pathway and autophagy.
Huang X; Zhang W; Pu F; Zhang Z
Genes Dis; 2023 Mar; 10(2):531-541. PubMed ID: 37223512
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis.
Wei H; Chen F; Chen J; Lin H; Wang S; Wang Y; Wu C; Lin J; Zhong G
Int J Nanomedicine; 2022; 17():3483-3495. PubMed ID: 35959282
[TBL] [Abstract][Full Text] [Related]
11. Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy.
Zhu Q; Ling X; Yang Y; Zhang J; Li Q; Niu X; Hu G; Chen B; Li H; Wang Y; Deng Z
Adv Sci (Weinh); 2019 Mar; 6(6):1801899. PubMed ID: 30937268
[TBL] [Abstract][Full Text] [Related]
12. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
Zhang CL; Zhu KP; Shen GQ; Zhu ZS
Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MEG3 inhibits proliferation and promotes apoptosis of osteosarcoma cells through regulating Notch signaling pathway.
Chen L; Wang J; Li JW; Zhao XW; Tian LF
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):581-590. PubMed ID: 32016959
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
Wang Z; Liu Z; Wu S
Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
[TBL] [Abstract][Full Text] [Related]
16. Activation of Dynamin-Related Protein 1 and Induction of Mitochondrial Apoptosis by Exosome-Rifampicin Nanoparticles Exerts Anti-Osteosarcoma Effect.
Chen W; Lin W; Yu N; Zhang L; Wu Z; Chen Y; Li Z; Gong F; Li N; Chen X; He X; Wu Y; Zeng X; Yueh Y; Xu R; Ji G
Int J Nanomedicine; 2022; 17():5431-5446. PubMed ID: 36426375
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA HCG11 enhances osteosarcoma phenotypes by sponging miR-1245b-5p that directly inhibits plakophilin 2.
Yan H; Zhou Y; Chen Z; Yan X; Zhu L
Bioengineered; 2022 Jan; 13(1):140-154. PubMed ID: 34949159
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA and circular RNA and coding RNA profiling of plasma exosomes of osteosarcoma by RNA seq.
Liu Y; Tang H; Li C; Huang N; Miao J; Chen L; Luo K; Li F; Liu S; Liao S; Feng W; Zhan X; Xie T; Tang W; Wei Q; Lu J
Sci Data; 2023 Jun; 10(1):395. PubMed ID: 37349312
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNAs in osteosarcoma.
Chen R; Wang G; Zheng Y; Hua Y; Cai Z
Oncotarget; 2017 Mar; 8(12):20462-20475. PubMed ID: 28103585
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension.
Xing Y; Zheng X; Fu Y; Qi J; Li M; Ma M; Wang S; Li S; Zhu D
Mol Ther; 2019 Dec; 27(12):2166-2181. PubMed ID: 31477557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
